Faubel-Booklet Labels
September 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Faubel-Booklet Labels with temperature indicators from ELPRO identify and monitor pharmaceutical products Melsungen, 3rd of September 2018Pharmaceutical products without proper …
Widening the focus on innovations in cancer treatment
September 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andME, CRUK, Cancer, GSK, diagnosis, genetics, oncology, pharma
Cancer treatment is making leaps and bounds, but public focus tends to gravitate towards the therapies themselves. Matt Fellows explores …
FDA rejects Sunovion’s ADHD drug dasotraline
September 3, 2018Sales and Marketing ADHD, FDA, dasotraline, drug, sunovion
The US Food and Drug Administration (FDA) have rejected American pharma firm Sunovion’s application to market dasotraline for the treatment …
Dutch doctors resist pharma firm’s 500-fold price hike
September 3, 2018Sales and Marketing Netherlands, leadiant, pharma, pricing
A group of Dutch doctors and health advocates are taking action against the Italian pharmaceutical firm Leadiant Biosciences who have …
The September 2018 issue of Pharmafocus is available to read online now!
September 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, AstraZeneca, Cancer, Iraw, J&J, JJ, Pfizer, Roche, UK, brexit, drug safety, pharma, pharmacovigilance
The new September edition of Pharmafocus is now live and available to read online. We’re entering the final stretch as …
AI used to forecast cancer progression
September 3, 2018Sales and Marketing AI, Cancer, ICR, London, ai drug research and development, university of edinburgh
A team of scientists at the Institute of Cancer Research (ICR) in London and the University of Edinburgh have developed …
MHRA loses EMA contracts in wake of Brexit
September 3, 2018Sales and Marketing EMA, MHRA, UK, brexit, contracts, politics, regulation
The EMA has awarded Britain’s regulatory body the MHRA just two contracts this year, as the European agency suggested that …
Top Ten most popular articles on Pharmafile.com this week
August 31, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Eisai, Medicare, Novartis, UK, brexit, generics, king bio, pharma, top ten
Eight months of 2018 down – where has the year gone? As we move from August into September, and a …
DIA’s Global Clinical Trials Transparency Conference & Clinical Trials Regulations Conference
August 31, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Disclosure and transparency of clinical trial information is taking on new dimensions in the EU and US. Moreover, while the …
Global orphan and rare dermatology market set to exceed $6 billion by 2024
August 31, 2018Medical Communications Orphan Drugs, analysis, dermatology, market reports, rare diseases
The global orphan and rare dermatology premium products market is expected to grow rapidly in the next half a decade …
Shire hands over its oncology franchise to Servier for $2.4bn
August 31, 2018Medical Communications, Sales and Marketing Cancer, Servier, Shire, oncology, pharma, sale
Shire has completed the sale of its oncology franchise to French firm Servier for $2.4 billion, handing over the global …
Trump administration resists WHO efforts to tackle antimicrobial resistance
August 31, 2018Medical Communications AMR, Trump, US, US government, WHO, antimicrobial resistance
The Trump administration is in the process of drafting an alternative to the World Health Organization’s guidelines on the use …
AZ’s lupus drug fails to curb lupus activity at Phase 3
August 31, 2018Medical Communications, Research and Development AstraZeneca, Lupus, anifrolumab, pharma
AstraZeneca and its biologics R&D arm MedImmune have released a statement admitting that their fully human monoclonal antibody anifrolumab failed …
Bristol-Myers Squibb appoints Christopher Boerner as new Executive Vice President and Chief Commercial Officer
August 30, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, bristol myers squibb, cco, chief commercial officer, christopher boerner, executive vice president, murdo gordon
Bristol Myers Squibb has announced that Dr Christopher Boerner will take over from Murdo Gordon as executive Vice President and …
Contraceptive app Natural Cycles investigated over “misleading” efficacy claims
August 30, 2018Medical Communications, Sales and Marketing APP Pharma, Natural Cycles, UK, app. pharma
The company behind Natural Cycles, the first-ever approved smartphone app promising a natural alternative to contraception, has seen a Facebook …
Drug slows brain shrinkage associated with progressive multiple sclerosis, study shows
August 30, 2018Research and Development MS, brain, ibudilast, neuroscience, research
The multiple sclerosis drug ibudilast, slowed brain shrinkages in patients with progressive MS, a study published in the New England …
CBD dampens activity in brain regions associated with psychosis, study shows
August 30, 2018Research and Development CBD, King's College London, Kings College London, Marijuana, psychosis, study
Cannabidiol (CBD), one of the major constituents of cannabis, may be beneficial for patients with psychotic disorders due to its …
AstraZeneca’s once-weekly auto-injector Bydureon BCise wins EU approval in type 2 diabetes
August 30, 2018Research and Development, Sales and Marketing AstraZeneca, Bydureon, EU, Europe, diabetes, pharma, type 2 diabetes
AstraZeneca has announced that its auto-injector Bydureon BCise (exenatide 2mg prolonged-release suspension) has been approved by the European Commission for …
Opioid prescriptions hit 15 year low, as FDA’s Gottlieb reaffirms commitment against crisis
August 30, 2018Medical Communications FDA, opioid crisis, prescriptions, scott gottleib
The amount of opioids prescribed to patients in the United States has fallen to a 15 year low according to …
Jazz Pharma’s acute myeloid leukaemia drug scores EU approval
August 29, 2018Research and Development, Sales and Marketing Vyxeos, acute myeloid leukaemia, jazz pharmaceuticals, leukaemia, pharma
Jazz Pharmaceuticals has revealed that its advanced liposomal formulation Vyxeos has received approval from the European Commission for the treatment …
